JNJ Johnson & Johnson

$179.29

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Johnson & Johnson

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

Website: https://www.jnj.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
200406
Address
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, US
Valuation
Market Cap
$379.48B
P/E Ratio
17.52
PEG Ratio
1.07
Price to Book
5.31
Performance
EPS
$8.99
Dividend Yield
3.30%
Profit Margin
24.40%
ROE
20.10%
Technicals
50D MA
$159.66
200D MA
$156.75
52W High
$169.99
52W Low
$139.56
Fundamentals
Shares Outstanding
2B
Target Price
$169.47
Beta
0.48

JNJ EPS Estimates vs Actual

● Estimated
● Actual

JNJ News & Sentiment

Aug 22, 2025 • GlobeNewswire BULLISH
Tevogen Recognized in BINJE's BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma
WARREN, N.J., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Tevogen Bio Holdings Inc. ( "Tevogen" or the "Company" ) ( Nasdaq: TVGN ) , announced today that it has been named in BINJE's BEST Health Care 2025: Companies, Organizations and Service Providers.
Aug 22, 2025 • Zacks Commentary BULLISH
Why Johnson & Johnson ( JNJ ) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
Aug 22, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Stryker's Robotics and Global Gains Offset by Macro Concerns
SYK posted strong Q2 growth driven by Mako robotics and global demand, but inflation, FX and competitive pressures temper near-term upside.
Aug 22, 2025 • Zacks Commentary BULLISH
4 Medical Devices Behemoths to Buy Amid Extensive AI Applications
AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.
Aug 22, 2025 • Benzinga NEUTRAL
J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs - AstraZeneca ( NASDAQ:AZN ) , Biogen ( NASDAQ:BIIB )
Johnson & Johnson JNJ is set to invest $2 billion in its North Carolina facilities, expanding its U.S. manufacturing operations. This move comes in response to potential drug import tariffs proposed by the Trump administration. J&J announced its investment on Thursday, as reported by Reuters.
Aug 22, 2025 • Motley Fool SOMEWHAT-BULLISH
5 Vanguard ETFs to Buy With $500 and Hold Forever
These exchange-traded funds can provide a solid foundation for your portfolio.
Sentiment Snapshot

Average Sentiment Score:

0.210
50 articles with scored sentiment

Overall Sentiment:

Bullish

JNJ Reported Earnings

Apr 15, 2025
Mar 31, 2025 (Pre market)
0.18 Surprise
  • Reported EPS: $2.77
  • Estimate: $2.59
  • Whisper: —
  • Surprise %: 7.0%
Jan 22, 2025
Dec 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $2.04
  • Estimate: $2.01
  • Whisper: —
  • Surprise %: 1.5%
Oct 15, 2024
Sep 30, 2024 (Pre market)
0.21 Surprise
  • Reported EPS: $2.42
  • Estimate: $2.21
  • Whisper: —
  • Surprise %: 9.5%
Jul 17, 2024
Jun 30, 2024 (Pre market)
0.12 Surprise
  • Reported EPS: $2.82
  • Estimate: $2.70
  • Whisper: —
  • Surprise %: 4.4%
Apr 16, 2024
Mar 31, 2024 (Pre market)
0.07 Surprise
  • Reported EPS: $2.71
  • Estimate: $2.64
  • Whisper: —
  • Surprise %: 2.6%
Jan 23, 2024
Dec 31, 2023 (Pre market)
0.01 Surprise
  • Reported EPS: $2.29
  • Estimate: $2.28
  • Whisper: —
  • Surprise %: 0.4%
Oct 17, 2023
Sep 30, 2023 (Pre market)
0.14 Surprise
  • Reported EPS: $2.66
  • Estimate: $2.52
  • Whisper: —
  • Surprise %: 5.6%
Jul 20, 2023
Jun 30, 2023 (Pre market)
0.18 Surprise
  • Reported EPS: $2.80
  • Estimate: $2.62
  • Whisper: —
  • Surprise %: 6.9%
Apr 18, 2023
Mar 31, 2023 (Pre market)
0.18 Surprise
  • Reported EPS: $2.68
  • Estimate: $2.50
  • Whisper: —
  • Surprise %: 7.2%

Financials